Prescription drug · ANDA
Cephalexin NDC 61919-606
Cephalexin 500 mg/1 · Capsule · Oral · Direct_Rx
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 61919-606-20 | 6191906062061919060620 | 20 CAPSULE in 1 BOTTLE (61919-606-20)Marketed from Aug 14, 2019 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Cephalexin
- Generic name (nonproprietary)
- cephalexin
- Active ingredients
- Cephalexin — 500 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Direct_RxNDC labeler code 61919
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090836
- Marketing start
- Listing expires
- Other FDA classes
- Cephalosporins (Chemical structure)
- Identifiers
- Product ID 61919-606_4d288574-ca75-070f-e063-6394a90ac210SPL ID 4d288574-ca75-070f-e063-6394a90ac210SPL set ID 90148caf-4291-da8b-e053-2a95a90a9bd3RxCUI 309114UNII OBN7UDS42Y
- Pharmacologic class
- Cephalosporin Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N461919060620followed by a unit qualifier and the quantityPackage 61919-0606-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
1.1 Respiratory Tract Infections Cephalexin is indicated for the treatment of respiratory tract infections caused by susceptible isolates of Streptococcus pneumoniae and Streptococcus pyogenes. 1.2 Otitis Media Cephalexin is indicated for the treatment of otitis media caused by susceptible isolates of Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Moraxella catarrhalis. 1.3 Skin and Skin Structure Infections Cephalexin is indicated for the treatment of skin and skin structure infections caused by susceptible isolates of the following Gram-positive bacteria: Staphylococcus aureus and Streptococcus pyogenes. 1.4 Bone Infections Cephalexin i…
Excerpt only. Read the full label for complete information.
About NDC 61919-606
- What is NDC 61919-606?
- 61919-606 is the product NDC for Cephalexin, Cephalexin 500 mg/1 capsule, listed with the FDA by Direct_Rx. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Cephalexin.
- What is the active ingredient?
- Cephalexin.
- Who is the labeler?
- Direct_Rx, NDC labeler code 61919. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Cephalexin?
- 183 other product NDCs are listed under this name. See all Cephalexin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Cephalexin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Cephalexin | Cephalexin 500 mg/1 | CapsuleOral | Preferred Pharmaceuticals Inc. | 68788-4143 | 68788-4143-0168788-4143-0268788-4143-03+6 more |
| Cephalexin | Cephalexin 250 mg/1 | CapsuleOral | Preferred Pharmaceuticals Inc. | 68788-4167 | 68788-4167-0268788-4167-0368788-4167-04+3 more |
| Cephalexin | Cephalexin 125 mg/5mL | Powder, For suspensionOral | Aurobindo Pharma Limited | 59651-322 | 59651-0322-0159651-0322-02 |
| Cephalexin | Cephalexin 250 mg/5mL | Powder, For suspensionOral | Aurobindo Pharma Limited | 59651-323 | 59651-0323-0159651-0323-02 |
| Cephalexin | Cephalexin 500 mg/1 | CapsuleOral | Coupler LLC | 67046-1245 | 67046-1245-03 |
| Cephalexin | Cephalexin 250 mg/1 | CapsuleOral | AVKARE | 42291-006 | 42291-0006-50 |
| Cephalexin | Cephalexin 500 mg/1 | CapsuleOral | AVKARE | 42291-007 | 42291-0007-50 |
| Cephalexin | Cephalexin 500 mg/1 | CapsuleOral | Northwind Health Company, LLC | 82868-095 | 82868-0095-1082868-0095-2082868-0095-21+3 more |
| Cephalexin | Cephalexin 250 mg/5mL | For suspensionOral | REMEDYREPACK INC. | 70518-4511 | 70518-4511-00 |
| Cephalexin | Cephalexin 250 mg/1 | CapsuleOral | Coupler, LLC | 67046-1533 | 67046-1533-03 |
Other NDCs under ANDA 090836
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Cephalexin | Cephalexin 250 mg/1 | CapsuleOral | Major Pharmaceuticals | 0904-7336 |
| Cephalexin | Cephalexin 500 mg/1 | CapsuleOral | Major Pharmaceuticals | 0904-7337 |
| Cephalexin | Cephalexin 500 mg/1 | CapsuleOral | QPharma Inc | 42708-070 |
| Cephalexin | Cephalexin 250 mg/1 | CapsuleOral | QPharma Inc | 42708-145 |
| Cephalexin | Cephalexin 250 mg/1 | CapsuleOral | PD-Rx Pharmaceuticals, Inc. | 43063-497 |
| Cephalexin | Cephalexin 500 mg/1 | CapsuleOral | PD-Rx Pharmaceuticals, Inc. | 43063-536 |
| Cephalexin | Cephalexin 500 mg/1 | CapsuleOral | PD-Rx Pharmaceuticals, Inc. | 43063-634 |
| Cephalexin | Cephalexin 250 mg/1 | CapsuleOral | PD-Rx Pharmaceuticals, Inc. | 43063-678 |
| Cephalexin | Cephalexin 500 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-3199 |
| Cephalexin | Cephalexin 250 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-3202 |
| Cephalexin | Cephalexin 500 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-3252 |
| Cephalexin | Cephalexin 250 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-3291 |
| Cephalexin | Cephalexin 500 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-3427 |
| Cephalexin | Cephalexin 500 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-5948 |
| Cephalexin | Cephalexin 500 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-7026 |
| Cephalexin | Cephalexin 500 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-7027 |
| Cephalexin | Cephalexin 500 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-7223 |
| Cephalexin | Cephalexin 250 mg/1 | CapsuleOral | AvPAK | 50268-151 |
| Cephalexin | Cephalexin 500 mg/1 | CapsuleOral | AvPAK | 50268-152 |
| Cephalexin | Cephalexin 250 mg/1 | CapsuleOral | American Health Packaging | 60687-152 |
Showing 20 of 39.